NCT05826444 - Microvascular Cardiac Allograft Vasculopathy Trial | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Cardiac Allograft Vasculopathy

Interventions

DIAGNOSTIC_TEST

Echocardiography

Echocardiography with afterload change

DIAGNOSTIC_TEST

Magnetic resonance imaging

Stress-MRI

DIAGNOSTIC_TEST

Magnetocardiography

DIAGNOSTIC_TEST

Histology

Histological analysis

DIAGNOSTIC_TEST

Genetics

miRNA sequencing

DIAGNOSTIC_TEST

calcium signaling

cardiomyocyte calcium signaling

DIAGNOSTIC_TEST

IMR

Index of microvascular resistance measurement

DIAGNOSTIC_TEST

Angio-IMR

Angiography derived post-processing index if microvascular resistance

Trial Locations (1)

RECRUITING

DHZC Deutsches Herzzentrum der Charité, Berlin